Printer Friendly

BIOPOOL REPORTS RECORD YEAR-END RESULTS

 VENTURA, Calif., March 15 /PRNewswire/ -- Biopool International Inc. (NASDAQ: BIPL) today reported record sales and earnings for the year and fourth quarter ended Dec. 31, 1992.
 For the 12 months ended Dec. 31, 1992, Biopool posted net income of $626,670, or $.09 per share, on sales of $4,865,334, compared with a net loss of $351,652, or $.07 per share, on sales of $2,662,087 last year.
 For the fourth quarter ended Dec. 31, 1992, the company registered net income of $188,292, or $.02 per share, on sales of $956,898. This compares with a net loss of $202,470, or $.04 per share, on sales of $762,160 for the same period in 1991. The 1991 fourth quarter includes a special charge for the writedown of $160,260 for patents and certain equipment.
 "We are very pleased to announce our first profitable year," said Michael D. Bick, Ph.D., chief executive officer. "Our aggressive strategy of penetrating new markets and expanding existing markets for our products as well as new product introductions favorably impacted our earnings."
 Bick added that Biopool is optimistic that 1993 will be a year of positive growth for the company. The recent announcement that Biopool's products will be distributed in China gives the company a potentially large untapped market for its test kits.
 Founded in 1987, Biopool develops, manufactures and markets a full range of test kits to assess and diagnose disorders of blood coagulation, fibrinolysis, platelet function and the vascular system, as well as test kits to determine thrombotic risk factors. The company's products are sold to hospitals and clinical laboratories worldwide.
 BIOPOOL INTERNATIONAL, INC.
 Selected Financial Data
 Three Months Ended Year Ended
 Dec. 31, Dec. 31,
 1992 1991(a) 1992 1991(a)
 (Unaudited) (Unaudited) (Audited) (Audited)
 Operations Data
 Sales $956,898 $762,160 $4,865,334 $2,662,087
 Income (loss)
 before non-
 operating items 208,324 (14,173) 739,176 (292,610)
 Net income (loss) 188,292 (202,470) 626,670 (351,652)
 Net income (loss)
 per share $.02 ($.04) $.09 ($.07)
 Dec. 31, 1992 Dec. 31, 1991
 (Audited) (Audited)
 Balance Sheet Data
 Working capital $1,298,328 $680,948
 Total assets 4,094,906 2,526,501
 Long-term debt 476,042 576,989
 Total shareholders'
 equity $2,556,585 $1,036,921
 (a) Includes a writedown of $160,260 for patents and certain equipment.
 -0- 3/15/93
 /CONTACT: Michael D. Bick, Ph.D., CEO, 805-654-0643, or Andrew L. Cerskus, Ph.D., president (in Canada), 416-332-9419, both of Biopool International; or Kim P. Feazle or Roger S. Pondel of Pondel Parsons & Wilkinson, 310-207-9300, for Biopool International/
 (BIPL)


CO: Biopool International Inc. ST: California IN: MTC SU: ERN

LS-KJ -- LA006 -- 5903 03/15/93 09:11 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 15, 1993
Words:460
Previous Article:HOLIDAY RV SUPERSTORES ANNOUNCES IMPROVED FIRST QUARTER EARNINGS
Next Article:BERGEN BRUNSWIG REPORTS SECOND QUARTER AND FIRST HALF RESULTS
Topics:


Related Articles
BIOPOOL REPORTS FIRST PROFITABLE QUARTER FROM OPERATIONS
BIOPOOL REPORTS SECOND CONSECUTIVE PROFITABLE QUARTER
BIOPOOL'S PROFITABILITY CONTINUES WITH THIRD QUARTER RESULTS
BIOPOOL REPORTS FIRST QUARTER RESULTS AND FIFTH CONSECUTIVE PROFITABLE QUARTER
BIOPOOL POSTS SECOND QUARTER OPERATING RESULTS
BIOPOOL REPORTS THIRD QUARTER RESULTS
BIOPOOL REPORTS YEAR-END RESULTS
BIOPOOL REPORTS FIRST QUARTER RESULTS; EARNINGS UP THREEFOLD
BIOPOOL REPORTS INCREASED SALES AND EARNINGS FOR THIRD QUARTER
BIOPOOL INTERNATIONAL REPORTS RECORD SALES AND EARNINGS FOR 1994

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters